amiodarone has been researched along with Cancer of Prostate in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitrakas, AG | 1 |
| Kalamida, D | 1 |
| Koukourakis, MI | 1 |
| Theodossiou, TA | 1 |
| Galanou, MC | 1 |
| Paleos, CM | 1 |
| Vodovar, D | 1 |
| Mongardon, N | 1 |
| Moachon, L | 1 |
| Arnaout, M | 1 |
| Beuzeboc, P | 1 |
| Lokiec, F | 1 |
| Rezai, K | 1 |
| Pène, F | 1 |
| Willan, AR | 1 |
| Lin, DY | 1 |
4 other studies available for amiodarone and Cancer of Prostate
| Article | Year |
|---|---|
Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity.
Topics: Amiodarone; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Docetaxel; Drug Resis | 2014 |
Novel amiodarone-doxorubicin cocktail liposomes enhance doxorubicin retention and cytotoxicity in DU145 human prostate carcinoma cells.
Topics: Amiodarone; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Mult | 2008 |
Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Atrial Fibrillation; Docetaxel; Dro | 2011 |
Incremental net benefit in randomized clinical trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Cost-Benefit Analysis; Defibrillators, Im | 2001 |